tirzepatide in mash Newly released phase IIb 48-week liver biopsy data on #tirzepatide #MASH. 73.9% resolution of with no worsening of fibrosis on 15 mg. Secondary endpoint ⬇️ fibrosis by >1 stage Tirzepatide: A Game-Changer for MASH
Description
Most symptoms were mild to moderate and were addressed by dose modification or dose escalation deceleration
Room temperature solution is more comfortable than cold solution, so let the syringe warm in your hand for 30 seconds after drawing the dose (but do not leave the vial out of the fridge)
Semaglutide-induced status epilepticus
Physical activity enhances both weight loss and glycemic control when combined with tirzepatide
"The pill was a great example of people getting confident that we can do this, that at Novo Nordisk, better days are ahead of them and not just behind," he said
Heres how it works: Consultation Well discuss your goals, health history, and if GLP-1 medication is right for you
